Symbol="IKNA"
AssetType="Common Stock"
Name="Ikena Oncology Inc"
Description="Ikena Oncology, Inc., a targeted oncology company, is focused on developing new cancer therapies that target key signaling pathways that drive cancer formation and spread. The company is headquartered in Boston, Massachusetts."
CIK="1835579"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="50 NORTHERN AVE., BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="265111000"
EBITDA="-68655000"
PERatio="None"
PEGRatio="None"
BookValue="3.724"
DividendPerShare="0"
DividendYield="0"
EPS="-1.72"
RevenuePerShareTTM="0.484"
ProfitMargin="0"
OperatingMarginTTM="-3.958"
ReturnOnAssetsTTM="-0.228"
ReturnOnEquityTTM="-0.403"
RevenueTTM="17547000"
GrossProfitTTM="-48703000"
DilutedEPSTTM="-1.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.57"
AnalystTargetPrice="17.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.126"
PriceToBookRatio="0.66"
EVToRevenue="0.208"
EVToEBITDA="0.968"
Beta="0.835"
num_52WeekHigh="7.64"
num_52WeekLow="1.94"
num_50DayMovingAverage="6.48"
num_200DayMovingAverage="4.295"
SharesOutstanding="36270000"
DividendDate="None"
ExDividendDate="None"
symbol="IKNA"
open="6.27"
high="6.43"
low="5.92"
price="6.09"
volume="73184.00"
latest_trading_day="2023-07-24"
previous_close="6.27"
change="-0.18"
change_percent="-2.8708%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="94097"
Change_recent_avg="0.03"
Delta_recent_avg="0.51"
Variance_recent_avg="0.25"
Change_ratio_recent_avg="0.45"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="582"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="951"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_positive_thumbnail_id_2="638"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0070.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
